Immunodiagnostics Market

Market Definition:

Global Immunodiagnostics Market size was valued at USD 18.39 billion in 2020 and is predicted to reach USD 27.07 billion by 2030 with a CAGR of 3.9% from 2021-2030.

Immunodiagnostics is a branch of in-vitro diagnostics that uses antigen-antibody reaction for the diagnosis of infectious and chronic diseases. They use radiological, fluorescent or color-forming enzymes and probes to monitor disease progression by detecting antibodies that aid the enhancement of targeting range. Various reagents, instruments and software-based solutions are also used for enzyme-linked immunosorbent assay, radioimmunoassay, chemiluminescence, and rapid testing.

These techniques are widely used to diagnose cancer, autoimmune, cardiovascular, infectious, respiratory and endocrine diseases among others. Moreover, immunodiagnostics techniques are also used in environmental and food analysis applications.

Market Dynamics and Trends:

Factors attributing to the rise of immunodiagnostic market is the increasing prevalence of infectious diseases such as respiratory infections, HIV infection and other infectious diseases along with increasing geriatric population. Also, technological advancements in the diagnostic kits and the increasing use of immunodiagnostic technology in rapid and instant test kits are driving the growth of the market. In addition, the rising interest of major players in innovative immunodiagnostic technologies such as automated systems, custom integrated laboratory systems and on-site testing, etc. along with the growth of immunodiagnostic laboratories have further promoted the growth of the market.

However, high cost, and stringent government regulations, may limit the growth of the immunodiagnostics market during the forecast period. On the other hand, the scientific developments on diagnostic kits, assays and analyzers, and the increased awareness of patients and medical professionals about preventive health measures, are expected to further create lucrative the growth of the immunodiagnostic market in future.

Market Segmentations and Scope of the Study:

The immunodiagnostic market is segmented on the basis of product, technology, application and end user. On the basis of product, the market is segmented into instruments, reagents and consumables, and software and services. Based on technology, the market is segmented into enzyme-linked immunosorbent assay, chemiluminescence immunoassay, fluorescent immunoassay, radioimmunoassay, rapid test, and others. Based on application, the market is divided into infectious diseases, oncology and endocrinology, bone and mineral, autoimmunity disorders, cardiac biomarker, drug monitoring among others. Based on end user, the market is divided into hospitals, clinical laboratories, academic and research centres, among others. Based on geography, the market is segmented into North America, Europe, Asia Pacific and RoW.

Geographical Analysis:

North America region holds the largest immunodiagnostics market share in immunodiagnostics market and is anticipated to continue dominating the market during the forecast period. This is attributable to factors including demand for immunodiagnostics tests, increasing geriatric population, growing prevalence of chronic and infectious diseases, and high consumer awareness.

Asia-Pacific region is expected to grow with the highest CAGR during the forecast period owing to improvement in the public & private healthcare facility, favourable regulatory reforms, presence of large population pool, and prevalence of chronic diseases. Moreover, rising number of new product approvals and adequate reimbursement for tests and products are factors expected to accelerate the growth of immunodiagnostics market in this region.

Competitive Landscape:

The immunodiagnostic market comprises of various market players such as Abbott Laboratories, Arkray Inc., Immunodiagnostic Systems Holdings plc (IDS), Bio-Rad Laboratories Inc., DiaSorin S.p.A., F. Hoffmann-La Roche Ltd, Johnson & Johnson, Danaher Corporation, Sysmex Corporation and Thermo Fisher Scientific Inc. Strategic alliances, acquisitions and innovations along with various R&D activities are key strategies adopted by market players to maintain their dominance in the market.

For instance, in September 2020, Immunodiagnostic Systems Holdings plc (IDS) launched four new i-Tracker assays designed to run on its automated IDS-iSYS analyser. It is a drug measuring kit, which measures the serum/plasma concentration of biological products used in the treatment of many inflammatory diseases. Also, in April 2021, DiaSorin launched LIAISON IQ reader and Immunodiagnostic PointofCare (POC). LIAISON IQ detects specific IgG antibodies against the SARSCoV2 spike protein in human capillary blood from a fingertip within 10 minutes.

Key Benefits

• The report offers quantitative analysis of the current immunodiagnostic market and estimations through 2020-2030, that assists in identifying the prevailing market opportunities to capitalize on. 

• The study comprises a deep dive analysis of the immunodiagnostic market trend including the current and future trends for depicting prevalent investment pockets in the immunodiagnostic industry.

• The report contains information related to key drivers, restraints and opportunities and their impact on the immunodiagnostic market.

• The report includes key market players, market share, which helps understand their competitive analysis.

• The competitive analysis of the market players along with their market share in the immunodiagnostic market.

• The SWOT analysis and Porter's Five Forces model is elaborated in the study.

• Value chain analysis in the market study provides a clear picture of the stakeholder’s role.

Key Market Segments:

By Product:

• Reagents & Consumables

• Instruments

• Software and Services

By Technology:

• Enzyme-Linked Immunosorbent Assay

• Chemiluminescence Immunoassay

• Fluorescent Immunoassay

• Radioimmunoassay

• Rapid Test

• Others

By Application:

• Infectious Diseases

• Oncology and Endocrinology

• Bone and Mineral Diseases

• Autoimmunity Disorders

• Cardiac Biomarkers

• Drug Monitoring

• Others

By End User:

• Hospitals

• Clinical Laboratories

• Academic and Research Centres

• Others

By Geography:

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Rest of Europe

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • Rest of Asia Pacific

• Row

  • Latin America

  • Middle East

  • Africa

KEY PLAYERS:

• Abbott Laboratories

• Arkray, Inc.

• Immunodiagnostic Systems Holdings Plc

• Diasorin S.P.A.

• Johnson & Johnson Services, Inc.

• F. Hoffmann-La Roche Ltd.

• Sysmex Corporation

• Danaher Corporation

• Thermo Fisher Scientific, Inc.

• Bio-Rad Laboratories, Inc.

REPORT SCOPE AND SEGMENTATION:

Parameters	Details
Analysis Period	2019–2030
Base Year Considered	2020
Forecast Period	2021–2030
Market Size Estimation	Billion (USD)
Market Segmentation	By Product (Instruments, Reagents & Consumables and Software and Services), by Technology (Enzyme-Linked Immunosorbent Assay, Chemiluminescence Immunoassay, Radioimmunoassay, Fluorescence Immunoassay, Rapid Tests and Others), By Application (Infectious Diseases, Oncology and Endocrinology, Bone and Mineral Diseases, Autoimmunity Disorders, Cardiac Biomarkers, Drug Monitoring and Other Applications), By End-user (Hospitals, Clinical Laboratories, Academic and Research Cent, and Others)
Geographical Segmentation	North America (U.S., Canada, Mexico) Europe (UK, Germany, France, Rest of Europe), Asia-Pacific (Japan, China, India, Australia, Rest of Asia Pacific), Rest of the World (Latin America, Middle East, Africa)
Companies Profiled	Abbott Laboratories, Arkray Inc., bioMérieux SA, Immunodiagnostic Systems Holdings plc (IDS), Bio-Rad Laboratories Inc., DiaSorin S.p.A., F. Hoffmann-La Roche AG, Johnson & Johnson, Siemens AG, Sysmex Corporation and Thermo Fisher Scientific Inc.